Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. Int. J. Environ. Sci. 2025;11(12s):1360-1367. doi:10.64252/8crhea08